← Back to Search

Cell Replacement Therapy

VC-01 Combination Product for Type 1 Diabetes (VC01-103 Trial)

Phase 1 & 2
Waitlist Available
Led By Manasi Jaiman, MD
Research Sponsored by ViaCyte
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 4, 8, 12 and 26
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if implanting new cells can safely and effectively help people with Type 1 Diabetes control their blood sugar levels over time.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 4, 8, 12 and 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 4, 8, 12 and 26 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cohort 1: The Percentage of Graft Cells Present at Post-implant Time Points Relative to Pre-clinical Models
Cohort 2: The Change in AUC (Area Under Curve) From Baseline to Week 26 in C-peptide During 4-hour MMTT

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sentinel units (aka Cohort 1)Experimental Treatment1 Intervention
VC-01 Combination Product; Up to ten (10) VC-01 sentinels
Group II: Dose-finding units (aka Cohort 2)Experimental Treatment1 Intervention
VC-01 Combination Product; Up to twelve units implanted of which up to nine (9) are VC-01-DF (dose-finding) implants and the rest are VC-01 sentinels

Find a Location

Who is running the clinical trial?

ViaCyteLead Sponsor
6 Previous Clinical Trials
169 Total Patients Enrolled
Manasi Jaiman, MDPrincipal InvestigatorViaCyte, Inc.
Howard Foyt, MD, PhDPrincipal InvestigatorViaCyte, Inc.
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top